2-(1-(3-Chloropropyl)piperidin-4-yl)ethanol, 95%, 250mg

1-[6-(Trifluoromethyl)pyrimidin-4-yl]piperidine-4-carboxylic acid, 95%, 500mg

4,4'-((Perfluoro-[1,1'-biphenyl]-4,4'-diyl)bis(oxy))dibenzonitrile, 98%, 250mg

3-Methoxy-3-methylbutyl acetate, min. 98%, for synthesis, 2.5 L, glass packaging

5-(4-Bromo-phenyl)-4-methyl-4H-[1,2,4]triazole-3-thiol, 95.0%, 5g

3-Fluoro-2-methoxy-5-methylbenzoic acid, 98%, 500mg

Pyridoxine Hydrochloride>98.0%(HPLC)(T)500g

5H-Pyrrolo[3,4-b]pyridine-5,7(6H)-dione, 95.0%, 5g

3-Chloro-2-nitrotoluene, 95.0%, 100g

3-Vinylbicyclo[4.2.0]octa-1,3,5-triene, 95.0%, 250mg

7-cyclohexyl-4-piperidin-4-yl-1,4-diazepane-2,5-dione hydrochloride, 50mg

2-Fluoro-5-iodophenol, 95.0%, 1g

(S)-2,4-bis((tert-butoxycarbonyl)amino)butanoic acid, 96%, 5g